International Tobacco Control Workshop March 24–26, 2015
Ankara, Turkey
Workshop Background and Objectives
Turkey has become a regional leader in tobacco control and is the first country in the world to fully implement all five WHO MPOWER measures to protect people from tobacco smoke. A ban on smoking in all indoor workplaces and public spaces; a comprehensive ban on tobacco advertising, promotion, and sponsorship; and graphic warning labels are some of the key measures that have been introduced. Thus far, preliminary evidence suggests that these measures have been successful in reducing smoking prevalence, secondhand smoke exposure, and related health and economic costs. Turkey also hosted the European Conference on Tobacco or Health in March 2014.
The workshop objectives are to support research capacity in tobacco control in Turkey and the neighboring region while building greater collaboration among U.S., Turkish, and regional tobacco control specialists and government representatives. The agenda addresses current research activities in Turkey; research gaps and needs in Turkey and the region; tobacco research funding mechanisms, including NCI/NIH and other agencies; 50 years of progress in tobacco control in the United States; experience from U.S.-funded investigators in capacity-building and international research; and a discussion of recommendations for collaborative research activities.
List of Acronyms
CiPHR—Center for Innovative Public Health Research
FCTC—Framework Convention on Tobacco Control FDA—Food and Drug Administration (U.S.)
GNAT—Grand National Assembly of Turkey MOH—Ministry of Health
NCI—National Cancer Institute (U.S.) NIH—National Institutes of Health (U.S.)
Q&A —Question-and-Answer
TAPDK—Tobacco and Alcohol Market Regulatory Authority (Turkey) TÜBITAK—Scientific and Technological Research Council of Turkey UICC—Union of International Cancer Control
Agenda
Master of Ceremony: Dr. Burcu Küçük Biçer, Hacettepe University, Turkey Day 1—8:30 a.m. – 5:10 p.m.
8:30 a.m. – 9:00 a.m. Participant Registration
9:00 a.m. – 9:45 a.m. Welcome and Introductions—NCI, NIH; WHO; MOH, Turkey; TAPDK; Hacettepe University; and GNAT Dr. Mark Parascandola, Epidemiologist, Tobacco Control
Research Branch, NCI, NIH
Mr. Y. Mehmet Kontas, Acting Head, WHO Country Office in Turkey
Dr. Bekir Keskinkılıç, Vice President of Turkish Public Health Institution and Head of Non-Communicable Diseases, Woman and Child Health Branch, Ministry of Health, Turkey
Mr. Seyit Ali Kurtuluş, Acting President, Tobacco and Alcohol Market Regulatory Authority, Turkey
Prof. Dr. A. Murat Tuncer, Rector, Hacettepe University, Turkey Prof. Dr. Cevdet Erdöl, Member of Parliament (Ankara), Former
President of Health, Family, Labor and Social Affairs Commission, Grand National Assembly of Turkey 9:45 a.m. – 10:00 a.m. Coffee and Tea Break
10:00 a.m. – 10:30 a.m. Outline and Objectives for the Workshop and Regional Participants Brief Introduction
Mark Parascandola, NCI, NIH
10:30 a.m. – 10:50 a.m. Evaluating Progress Toward FCTC Implementation (Skype)
Kristina Mauer-Stender, WHO
10:50 a.m. – 12:20 p.m. Session 1: Tobacco Control Progress in Turkey Chair: Tezer Kutluk, UICC
10:50 a.m. – 11:10 a.m. Patterns of Tobacco Use Prevalence in Turkey
Nazmi Bilir, Hacettepe University 11:10 a.m. – 11:30 a.m. Tobacco Control Activities in Turkey
Sertaç Polat, Head of Department of Tobacco and Addictive Substances, Turkey
11:30 a.m. – 11:50 a.m. Future Steps and Challenges of the Tobacco Control Program
L. Hilal Özcebe, Hacettepe University 11:50 a.m. – 12:20 p.m. Discussion and Q&A Session
12:20 p.m. – 1:20 p.m. Lunch
1:20 p.m. – 3:10 p.m. Session 2: U.S. Experience—50 Years of the Tobacco Epidemic
Chair: Ismail Çelik, Hacettepe University
1:20 p.m. – 1:40 p.m. Lessons From 50 Years of Tobacco Control Efforts
Mark Parascandola, NCI, NIH
1:40 p.m. – 2:00 p.m. Measuring Progress and the Impact of Tobacco Control Policies
David Levy, Georgetown University 2:00 p.m. – 2:20 p.m. Tobacco Regulatory Science
Cathy Backinger, FDA
2:20 p.m. – 2:40 p.m. Tobacco Cessation: Best Practices
Scott Leischow, Mayo Clinic 2:40 p.m. – 3:10 p.m. Discussion and Q&A Session 3:10 p.m. – 3:20 p.m. Coffee and Tea Break
3:20 p.m. – 5:10 p.m. Session 3: Research Topics
Chair: Ayşe Gökalp Kırca Çelik, TAPDK
3:20 p.m. – 3:40 p.m. Methods for the Measurement and Control of Illicit Tobacco Products (Skype)
Mark Goodchild , WHO
3:40 p.m. – 4:00 p.m. Tobacco Packaging, Labeling, and Promotion
Jim Thrasher, University of South Carolina 4:00 p.m. – 4:20 p.m. Measuring Tobacco Product Emissions
Mirjana Djordjevic, NCI, NIH 4:20 p.m. – 4:40 p.m. E-Cigarettes—General Overview
Rachel Grana, NCI, NIH 4:40 p.m. – 5:10 p.m. Discussion and Q&A Session 5:10 p.m. Adjourn for the Day
Day 2—9:00 a.m. – 4:50 p.m.
9:00 a.m. – 11:10 a.m. Session 4: Models of Research Collaboration Chair: Mutlu Hayran, Hacettepe University
9:00 a.m. – 9:20 a.m. Overview and Objectives for the Day
Marie Ricciardone, NCI, NIH
9:20 a.m. – 9:40 a.m. mCessation in Turkey
Michele Ybarra, CiPHR, and Aslı Çarkoğlu, Kadir Has University;
9:40 a.m. – 10:00 a.m. Quit Tobacco International: Overview and Lessons Learned in India and Indonesia
Mimi Nichter, University of Arizona 10:00 a.m. – 10:20 a.m. Cessation Research in Turkey
Mimi Nichter, University of Arizona, and Asli Çarkoğlu, Kadir Has University
10:20 a.m. – 10:40 a.m. WHO Tobacco Laboratory Network
Gemma Vestal, WHO
10:40 a.m. – 11:10 a.m. Discussion and Q&A Session 11:10 a.m. – 11:20 a.m. Coffee and Tea Break
11:20 a.m. – 12:20 p.m. Discussion Panel: Challenges and Opportunities for Building Research Networks and Collaborations Around Tobacco Control
Discussants: Michele Ybarra, CiPHR; Salih Emri, Hacettepe University; Asli Çarkoğlu, Kadir Has University; and Scott Leischow, Mayo Clinic
Facilitators: Mutlu Hayran, Hacettepe University, and Mark Parascandola, NCI, NIH
12:20 p.m. – 1:20 p.m. Lunch
1:20 p.m. – 2:20 p.m. Session 5: Funding Mechanisms for Tobacco Control Research and Training
Chair: Rachel Grana, NCI, NIH
1:20 p.m. – 1:40 p.m. NIH Research Portfolio in Tobacco Control and Cancer Prevention
Mark Parascandola, NCI, NIH
1:40 p.m. – 2:00 p.m. TÜBITAK Funding Opportunities
2:00 p.m. – 2:20 p.m. Opportunities for Non-Governmental Funding
Toker Ergüder, WHO
2:20 p.m. – 3:00 p.m. Global Tobacco Control Funders: Research for Action Discussants: Mark Parascandola, NCI, NIH; Toker Ergüder, WHO; Cathy Backinger, FDA; and Tezer Kutluk, UICC Facilitator: Tezer Kutluk, UICC
3:00 p.m. – 3:10 p.m. Coffee and Tea Break
3:10 p.m. – 4:50 p.m. Session 6: Research Capacity-Building Needs Assessment
Chair: Marie Ricciardone, NCI, NIH
3:10 p.m. – 3:50 p.m. Country-Specific Assessments of Tobacco Control
Toker Ergüder, WHO
3:50 p.m. – 4:50 p.m. Research Capacity-Building: Open Discussion
Facilitators: Scott Leischow, Mayo Clinic; and Jim Thrasher, University of South Carolina
4:50 p.m. Adjourn for the Day Day 3—9:00 a.m. – 1:00 p.m.
9:00 a.m. – 1:00 p.m. Session 7: Identifying Research Priorities and Areas for Collaboration
Chair: Toker Ergüder, WHO
9:00 a.m. – 9:15 a.m. Review and Commentary: What Have We Learned? Facilitator: Mark Parascandola, NCI, NIH
9:15 a.m. – 9:30 a.m. Coffee and Tea Break
9:30 a.m. – 11:15 a.m. Breakout Groups: Identify Research Gaps and Priorities in Tobacco Control and Opportunities To Enhance
Collaboration Facilitator(s): TBD
11:15 a.m. – 12:15 p.m. Report and Discussion: Breakout Groups To Report Back and the Full Group To Develop a Common List of
Recommendations for Collaborative Research Activities Facilitator(s): TBD
12:15 p.m. – 1:00 p.m. Discussion of Next Steps
Facilitators: Mark Parascandola, NCI, NIH and Nazmi Bilir, Hacettepe University
